Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes.
This study was aimed at evaluating whether the nitric oxide (NO)/cyclic GMP (cGMP) signaling pathway is altered in platelets from patients with an acute coronary syndrome (unstable angina and acute myocardial infarction). We investigated 10 patients with unstable angina (UA), 14 with acute myocardial infarction (AMI) and 14 age and sex-matched healthy subjects. The serum markers of platelet activation (sP-selectin), inflammation (TNF-alpha and erythrocyte sedimentation rate), thrombotic state (fibrinogen) and plaque disruption were significantly higher in both UA and AMI patients compared to the healthy controls. In their platelets we assessed the cGMP levels in basal conditions and after stimulation with sodium nitroprusside (SNP), and performed Western blot analysis of homogenates to measure the expression of soluble guanylate cyclase isoforms. Basal levels of cGMP (pmol/10(10) platelets) were significantly higher in platelets from UA patients (1,097 +/- 111; p < 0.0001) and AMI (1,122 +/- 77; p < 0.0001) compared to those collected from healthy controls (497 +/- 80). The platelets of AMI patients exhibited a lack of cGMP increase after SNP stimulation in comparison with UA patients. The phosphorylation of upstream (Akt1 protein kinase alpha and endothelial NO synthase) and downstream (vasodilator-stimulated phosphoprotein, VASP) signaling proteins of the NO/cGMP pathway was investigated: serine phosphorylation in Akt1, eNOS and VASP was enhanced in platelets from UA and AMI patients when compared to controls. Furthermore, in AMI patients the inhibitors of guanylate cyclase and cGMP-dependent protein kinase did not revert the VASP phosphorylation. These data suggest that platelets from AMI patients are more resistant to SNP stimulation, not only as cGMP production, but also in terms of VASP activation. From these ex vivo results we hypothesize that the increased inflammatory state which often accompanies patients with cardiovascular diseases might promote a platelet preactivation resulting in their reduced sensitivity to NO.
Bergandi
Loredana
L
Dipartimento di Genetica, Biologia e Biochimica (Sezione di Biochimica), University of Torino, Via Santena 5/bis, 10126, Turin, Italy. loredana.bergandi@unito.it
Cordero
Marco
M
Anselmino
Matteo
M
Ferraro
Gaetana
G
Ravera
Laura
L
Dalmasso
Paola
P
Moiraghi
Corrado
C
Trevi
Gian Paolo
GP
Ghigo
Dario
D
Bosia
Amalia
A
Bergerone
Serena
S
D054058:Acute Coronary Syndrome / Q000378:metabolism*; D000368:Aged; D001792:Blood Platelets / Q000378:metabolism*; D016022:Case-Control Studies; D006152:Cyclic GMP / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000096:biosynthesis*; D015398:Signal Transduction
D009569:Nitric Oxide; D006152:Cyclic GMP
Clin Res Cardiol. 2008 Jan;97(1):12-20
17938848
Hepatology. 2002 Feb;35(2):393-402
11826414
J Biol Chem. 2005 Nov 11;280(45):37430-8
16144836
Clin Res Cardiol. 2008 May;97(5):298-305
18491171
Cell. 2003 Jan 10;112(1):77-86
12526795
Trends Cell Biol. 2003 Jul;13(7):386-92
12837609
J Exp Med. 2004 Feb 2;199(3):347-56
14744991
Clin Res Cardiol. 2007 Sep;96(9):604-12
17593313
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):99-105
16269668
J Am Coll Cardiol. 2001 Jun 1;37(7):1851-7
11401122
Thromb Haemost. 1993 Jul 1;70(1):148-51
7694386
J Thromb Haemost. 2003 Oct;1(10):2112-8
14521592
Blood. 2005 Sep 15;106(6):1992-4
15956282
Eur Heart J. 2000 Sep;21(18):1502-13
10973764
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2661-6
16254202
Mol Pharmacol. 2003 Apr;63(4):886-95
12644590
Circ Res. 2008 Sep 12;103(6):598-605
18689572
Nature. 1999 Jun 10;399(6736):601-5
10376603
Blood. 2004 Sep 15;104(6):1703-10
15105289
Circ Res. 2000 Nov 24;87(11):999-1005
11090544
J Biol Chem. 2006 Jun 16;281(24):16333-9
16613861
Ann Med. 2003;35(1):21-7
12693609
Clin Res Cardiol. 2007 Nov;96(11):767-86
17955157
Platelets. 2002 Aug-Sep;13(5-6):307-11
12189017
Trends Biochem Sci. 2004 May;29(5):233-42
15130559
Clin Res Cardiol. 2008 Dec;97(12):851-64
18975022
Pharmacol Rep. 2005;57 Suppl:59-65
16415487
Lancet. 1995 Mar 18;345(8951):669-85
7661937
J Biol Chem. 2003 Aug 15;278(33):30725-31
12796499
Circ Res. 2003 Jul 25;93(2):96-105
12881475
J Leukoc Biol. 2009 Feb;85(2):195-204
18948548
Circulation. 1995 Oct 1;92(7):1693-6
7545552
J Exp Med. 1999 Apr 19;189(8):1255-64
10209042